# Menarini Group clinical trials: 28 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 28 trials with Menarini Group as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Menarini Group: 28 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/menarini-group

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 28
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 28, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 14, 2025 | NCT06828848 | A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But... | Menarini Group | Phase 2 | Recruiting | Gram Negative Infections | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06828848) |
| August 3, 2020 | NCT04495621 | MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01) | Menarini Group | Phase 1/2 | Completed | Metastatic Colorectal Cancer | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04495621) |
| August 1, 2019 | NCT04042077 | Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections | Menarini Group | Phase 3 | Terminated | Surgical Site Infection | 268 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04042077) |
| December 6, 2018 | NCT03767335 | MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer | Menarini Group | Phase 1 | Completed | Advanced or Metastatic Breast Cancer | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03767335) |
| July 30, 2018 | NCT03605212 | Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults | Menarini Group | Phase 1/2 | Terminated | Tumor Lysis Syndrome | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03605212) |
| January 19, 2018 | NCT03403725 | MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study | Menarini Group | Phase 1 | Terminated | Metastatic Solid Tumors, Relapsed/Refractory Non-Hodgkin Lymphoma | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03403725) |
| January 2, 2017 | NCT03008187 | MEN1703 (SEL24) in Participants With Acute Myeloid Leukemia | Menarini Group | Phase 1/2 | Completed | Acute Myeloid Leukemia | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03008187) |
| May 19, 2016 | NCT02777970 | Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted... | Menarini Group | Phase 4 | Completed | Acute Pain | 654 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02777970) |
| February 2, 2015 | NCT02353143 | Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia | Menarini Group | Phase 1 | Terminated | Recurrent Adult Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse | 71 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02353143) |
| December 19, 2014 | NCT02320318 | 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) | Menarini Group | Phase 3 | Withdrawn | Irritable Bowel Syndrome With Diarrhea | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02320318) |
| August 6, 2014 | NCT02209454 | Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet Formulations | Menarini Group | Phase 1 | Completed | Acute Pain | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02209454) |
| July 31, 2014 | NCT02205814 | Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee | Menarini Group | Phase 2 | Completed | Knee Osteoarthritis | 436 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02205814) |
| April 22, 2014 | NCT02120027 | 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) | Menarini Group | Phase 3 | Terminated | Irritable Bowel Syndrome With Diarrhea | 558 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02120027) |
| April 8, 2014 | NCT02107196 | 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) | Menarini Group | Phase 3 | Completed | Irritable Bowel Syndrome With Diarrhea | 535 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02107196) |
| July 22, 2013 | NCT01904149 | Oral Treatment for Gynaecological Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride | Menarini Group | Phase 3 | Completed | Acute Pain | 606 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01904149) |
| July 18, 2013 | NCT01902134 | Oral Treatment for Orthopaedic Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride | Menarini Group | Phase 3 | Completed | Acute Pain | 641 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01902134) |
| November 9, 2012 | NCT01724528 | Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies | Menarini Group | Phase 3 | Completed | Tumor Lysis Syndrome | 346 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01724528) |
| February 17, 2012 | NCT01534962 | Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion | Menarini Group | Phase 2 | Completed | Persistent Atrial Fibrillation | 241 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01534962) |
| February 14, 2012 | NCT01532518 | Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance | Menarini Group | Phase 2 | Completed | Colic | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01532518) |
| March 4, 2011 | NCT01309009 | Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment | Menarini Group | Phase 2 | Withdrawn | Infantile Colic | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01309009) |
| March 2, 2011 | NCT01307020 | Analgesic Effect of Different Combinations of Dexketoprofen Trometamol With Tramadol Hydrochloride in a Model of Moderate to Severe Pain | Menarini Group | Phase 2 | Completed | Pain | 745 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01307020) |
| February 24, 2011 | NCT01303224 | Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) | Menarini Group | Phase 2 | Completed | Irritable Bowel Syndrome With Diarrhea | 565 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01303224) |
| December 10, 2010 | NCT01258153 | Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic | Menarini Group | Phase 2 | Completed | Infantile Colic | 115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01258153) |
| March 23, 2010 | NCT01091116 | A Locally Injected Bradykinin Antagonist for TReatment of OSteoarthritiS | Menarini Group | Phase 2 | Completed | Osteoarthritis, Knee | 423 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01091116) |
| September 26, 2008 | NCT00761007 | Ibodutant for Relief of Irritable Bowel Syndrome (IRIS) | Menarini Group | Phase 2 | Completed | Irritable Bowel Syndrome | 554 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00761007) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Phase 1/2 | 3 |
| Phase 2 | 10 |
| Phase 2/3 | 1 |
| Phase 3 | 8 |
| Phase 4 | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 19 |
| Terminated | 6 |
| Withdrawn | 2 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Irritable Bowel Syndrome | 5 |
| Intestinal Diseases | 5 |
| Acute Pain | 4 |
| Pain, Postoperative | 4 |
| Colic | 4 |
| Diarrhea | 3 |
| Leukemia, Myeloid, Acute | 2 |
| Recurrence | 2 |
| Osteoarthritis, Knee | 2 |
| Tumor Lysis Syndrome | 2 |
| Arthritis | 1 |
| Hematologic Neoplasms | 1 |
| Atrial Fibrillation | 1 |
| Arrhythmias, Cardiac | 1 |
| Colorectal Neoplasms | 1 |
| Pain | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Neoplasm Metastasis | 1 |
| Abdominal Pain | 1 |
| Gastrointestinal Diseases | 1 |
| Hypertension | 1 |
| Ovarian Neoplasms | 1 |
| Leukemia | 1 |
| Lymphoma | 1 |
| Breast Neoplasms | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Mills in the United States](https://specstream.ai/data/businesses/mills/united-states)
- [Osteopathic practices in the United States](https://specstream.ai/data/businesses/osteopathic-practices/united-states)
- [Physical therapy clinics in the United States](https://specstream.ai/data/businesses/physical-therapy-clinics/united-states)
- [Psychiatric hospitals in the United States](https://specstream.ai/data/businesses/psychiatric-hospitals/united-states)
- [Sake bars in the United States](https://specstream.ai/data/businesses/sake-bars/united-states)
- [Specialized medical facilities in the United States](https://specstream.ai/data/businesses/specialized-medical-facilities/united-states)
